CPI-0610, a potent and selective BET bromodomain inhibitor optimized for clinical development
收藏NIAID Data Ecosystem2026-03-14 收录
下载链接：
https://www.ncbi.nlm.nih.gov/sra/SRP062069
下载链接
链接失效反馈官方服务：
资源简介：
SUDHL5 cells were treated with DMSO or 2.5 µM CPI203 for 4 hours, then processed for ChIP-Seq to obtain genome-wide binding changes for BRD4 upon treatment with a BET inhibitor. Overall design: Examination of BRD4 binding in the absence or presence of a BET inhibitor in SUDHL5 DLBCL cell line using ChIP-Seq
创建时间：
2023-01-06
